PW Magazine 39, jaar 2012

‘Only an international approach works’

The problems associated with resistant bacteria are rapidly increasing worldwide. The ecosystem is already contaminated. The number of victims of infection is growing, but a solution remains elusive.

28-09-2012 | door Elma Stitzinger

Looking at the future

Message from the PW Editor-in-chief

28-09-2012 | door Elma Stitzinger

Fake medicines: out of the supply chain

The battle to stop falsified medicines entering the supply chain is ongoing. Only last month, the Medicines and Healthcare products Regulatory Agency’s enforcement team seized a haul of counterfeit erectile dysfunction tablets with an estimated value of £140,000. To help tackle the problem the European Commission published the ‘Falsified Medicines Directive’, which could have considerable implications for pharmacists.

28-09-2012 | door Kate Towers

Personalised medicine: back to the future

Innovation in the field of pharmaceutical medicine is advancing faster than the healthcare system can adapt to it. Personalised medicine is widely acknowledged to be the future. Could the current trend see the return of the compounding pharmacist in our high streets?

28-09-2012 | door Dave Sharma

Creating a future

Message from the FIP President

28-09-2012 | door Michel Buchmann

Visit the pharmacy for medical apps

Apps on smartphones can play a key role in compliance. Using a game, patients set goals for themselves and share their scores on Facebook. Internet expert Martijn Hulst: “The pharmacy is the ideal place for providing medical apps.”

28-09-2012 | door Edwin Bos

Working towards a healthier world

For a full century, the International Pharmaceutical Federation (FIP) has brought together pharmacists and pharmaceutical scientists from around the world. The goal: to advance pharmacy practice and science so that they may ensure safe, cost-effective use of medicinal products.

28-09-2012 | door Edwin Bos

Price orphan drugs can be reduced drastically

Better diagnostic testing allows tailored therapy for an increasing number of diseases. This has led to a growing number of conditions classified as ‘orphan diseases’. A welcome source of income for the pharmaceutical industry, but a growing expense for society. It’s time for a change of course.

28-09-2012 | door J.R.B.J. Brouwers

Healthcare

Message from the Minister of Health, The Netherlands

28-09-2012 | door Edith Schippers

Essential link

Preface by the Chairman of the Royal Dutch Pharmacist's Association

28-09-2012 | door Jan Smits

Doubts about long-term use of ADHD medication

The long-term effects of ADHD medication are currently under investigation. There are concerns about psychiatric side effects and the cardiovascular safety of this medication. There have even been reports of deaths.

28-09-2012 | door Marc de Leeuw

The era of medical breakthroughs is not over

The era of groundbreaking inventions in the field of pharmacotherapy seems over, but there have recently been some giant leaps in two areas, type 1 diabetes and oncology.

28-09-2012 | door Marc de Leeuw

Swallowing problems: threat to compliance

Tens of thousands of pills and capsules are ground or broken up every day in order to mix them with yoghurt or soft drinks. The reason: they are either too large or have too rough a surface to be able to swallow them easily. Importantly, not all medicines may be processed.

28-09-2012 | door f.baltesen@pw.nl

Battle against medicine shortages can be won

Medicine shortages are a persistent and global problem. Preferential policy is only part of the cause. Authorities are looking for a solution, but their powers are limited. And yet, measures have proven effective.